Peptides DB
Research-centric peptide and protocol reference hub
Study 5 of 19Erythropoietin (EPO) literatureeuropepmc · Observational2026

Erythropoietin receptor upregulation is associated with tubular injury severity in human acute kidney injury.

EPOR expression is significantly higher in acute kidney injury compared to controls and correlates with injury severity, but the clinical implications of these findings need further investigation.

Read at europepmcAdd to compare

Where it sits

this study against the rest of the erythropoietin (epo) corpus
4
Preclinical
10
Observational · this one
0
Open-label
2
Randomised
3
Reviews

Summary and findings

This study investigated erythropoietin receptor (EPOR) expression in human acute kidney injury (AKI) by analyzing renal biopsy specimens from 21 patients with AKI and 12 control samples. The findings indicated that EPOR expression was significantly higher in AKI kidneys compared to controls, with various correlations to injury severity. No therapeutic claims are made.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
EPOR expression was significantly higher in AKI kidneys compared to controls, p<0.001.2026

Abstract

The authors’ words, as europepmc supplied them

<h4>Objective</h4>This study aimed to investigate erythropoietin receptor (EPOR) expression in human AKI and to examine its association with histopathological severity and clinical parameters.<h4>Methods</h4>Renal biopsy specimens from 21 patients with biopsy-confirmed acute kidney injury (AKI) and 12 control kidney tissues from nephrectomy samples were analyzed. EPOR expression was assessed by immunohistochemistry with AI-assisted digital quantification and by immunofluorescence, including co-staining with β-common receptor (βcR) and TUNEL.<h4>Results</h4>In human kidney biopsy specimens, EPOR expression was significantly higher in AKI kidneys compared to controls (<i>p</i> < 0.001). Immunofluorescence demonstrated co-localization of EPOR and βcR on tubular epithelial cell membranes. EPOR expression showed significant inverse correlations with stage of AKI (<i>τ</i> = -0.444, <i>p</i> = 0.012), tubular necrosis scores (<i>τ</i> = -0.485, <i>p</i> = 0.005), and acute pathology scores (<i>τ</i> = -0.475, <i>p</i> = 0.005). A significant positive correlation was found between EPOR expression and both red blood cell count (<i>r</i> = 0.490, <i>p</i> = 0.024) and Hemoglobin levels (<i>r</i> = 0.496, <i>p</i> = 0.022). Receiver operating characteristic analysis indicated moderate discriminatory performance of EPOR expression for differentiating AKI severity stages. Consistent with the human data, EPOR protein levels were significantly upregulated in mouse kidneys 24 h after ischemia-reperfusion injury. Single-cell transcriptomic analysis further demonstrated increased EPOR expression in tubular cell populations in AKI.<h4>Conclusions</h4>EPOR expression is upregulated in renal tubular epithelial cells in human AKI and is closely associated with histopathological injury severity and selected clinical parameters, highlighting that EPOR may serve as a marker of tubular stress and injury severity in AKI.

Background

The paper addresses the role of erythropoietin receptors in acute kidney injury (AKI), a condition characterized by rapid loss of kidney function. Prior research has indicated that erythropoietin may have protective effects in kidney injury, but the relationship between receptor expression and injury severity remains unclear. Understanding this relationship is crucial for developing potential therapeutic strategies.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Key findings

  • Not reported in abstract.

Limitations

  • Not reported in abstract.

Elsewhere in the Erythropoietin (EPO) corpus

CEffects of erythropoietin on cardiac morphometry in exercised male and female adolescent rats.Veterinary research forum : an international quarterly journal · 2025 · Not reported in abstract.AnimalANon-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial.Nephrology (Carlton, Vic.) · 2025 · Difference in response rates was 6.3% with 95% CI -3.1% to 15.5%.HumanAImpact of intravenous iron or exogenous erythropoietin on hemoglobin mass, exercise performance, and acute mountain sickness during altitude acclimatization.Journal of applied physiology (Bethesda, Md. : 1985) · 2025 · Absolute Hbmass (g) increased from SL and day 1 to day 13 (P < 0.0001).HumanDErythropoietin receptor on cDC1s dictates immune tolerance.Nature · 2026DAn acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration.Nature medicine · 2026DCasdatifan shows durable response linked to HIF-2α biology in kidney cancer.Nature · 2026